Wu et al showed a significant increase in CD4+ lymphocyte population after the HIFU treatment of osteosarcoma and renal cell carcinoma, and it may be associated with an activated systemic cellular immune response (15). The gene discussed is CD4; the disease is hereditary clear cell renal cell carcinoma.